ArticleThe Journal of clinical investigation2023

IL-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy.

Gürcan Tunalı et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.